Institut Paoli Calmettes
Marseille, Bouches du Rhone, 13009, France
NCT Number: NCT02859883
The monitoring and prognosis of patients with familial polyposis adenomatous rests on analysis of the transitional mucosa at the anal margin and especially on the tracking, characterization and resection of lesions of dysplasia type of high grade at the duodenal level, after total proctocolectomy. Currently, endoscopes with axial or lateral vision are used. The FUSE technology allows the simplification or even the improvement of patient surveillance with a 245° vision (versus150° in case of classical gastroscope). The use of a second screen to enlarge the field of view may allow both analysis of duodenum and the main and accessory papilla with one single endoscope and to decrease the number of omitted lesions .
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Marseille, Bouches du Rhone, 13009, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients undergoing a diagnostic gastroscopy are eligible. Using the FUSE endoscope with side screen, the duodenal and accessory papilla are monitored. Data are collected by each operator. Clinical examination of patients is performed before they leave the centre.
Time frame: 1 day
Visualization of minor and major papilla Absence of necessity to change endoscope for viewing and / or for biopsies
Time frame: 5 day
Evaluated serious advers events are mainly perforation, severe bleeding, acute pancreatitis
Institut Paoli-Calmettes
Other
Acronym: FUSE-TM-Duo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.